Michael Poisel

Michael Poisel is an experienced director with a proven track record in university spin-outs and venture capital.

He holds an MBA & MSSE in Entrepreneurial Management and Finance from The Wharton School, along with a BSME in Mechanical Engineering from Rose-Hulman Institute of Technology.

With a career spanning various reputable organizations, Michael has served in leadership roles such as Chief Executive Officer at PhylloPharma, and as a Board Director at Linnaeus Therapeutics, Inc., Exyn Technologies, and Ed Leadership Sims.

He has also held the role of Executive Director at PCI Ventures at the University of Pennsylvania, showcasing his expertise in the academic and entrepreneurial domains.

Additionally, Michael Poisel has been involved with several notable entities including the U.S. Department of State as a YTILI Reverse Fellow, the Greater Philadelphia Alliance for Capital & Technologies (PACT) as a Board Member, NewSpring as Principal, Apax Partners as a Partner, and GE Equity as a Venture Capital Associate.

His vast experience includes a role as Supervisor at GE Astrospace, further emphasizing his deep understanding of diverse industry sectors.

With a strong educational background and extensive professional experience, Michael Poisel is a respected figure in the fields of venture capital, entrepreneurial management, and university spin-outs.